Virus hepatitis b dna

Test Usage. Test Limitations. Days Set Up. Analytic Time. Soft Order Code. MiChart Code. Collection Instructions. Rejection Criteria. Specimens received in polystyrene aliquot tubes are unacceptable and will be rejected. Normal Volume.

Minimum Volume. Yee J. A liver-specific enhancer in the core promoter region of human hepatitis B virus. Hepatitis B virus DNA contains a glucocortcoid response element.

Huang J, Liang TJ. Mol Cell Biol. Klingmuller U, Schaller H. Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor.

Carboxypeptidase D gp , a Golgi-resident protein, functions in the attachment and entry of avian hepatitis B viruses. Phosphorylation of hepatitis B virus Cp at Ser87 facilitates core assembly. Biochem J. Kock J, Schilicht H-J. Analysis of the earliest steps of hepadnavirus replication genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity.

Internal entry of ribosomes and ribosomal scanning involved in hepatitis B virus P gene expression. The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid. Pollack J, Ganem D. Replication strategy of human hepatitis B virus. Viral hepatitis, type B. Studies on natural history and prevention re-examined. N Engl J Med. Liang TJ, Ghany M. Hepatitis B e antigen—the dangerous endgame of hepatitis B.

Antibody to hepatitis B core antigen in blood donors with a history of hepatitis. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.

Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.

Mol Diagn Ther. Loomba R, Liang TJ. Treatment of chronic hepatitis B. Antivir Ther. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state.

J Infect Dis. Barker LF, Murray R. Relationship of virus dose to incubation time of clinical hepatitis and time of appearance of hepatitis—associated antigen. Am J Med Sci. Berk PD, Popper H. Fulminant hepatic failure. Am J Gastroenterol. Fulminant hepatic failure: summary of a workshop. McMahon The natural history of chronic hepaatitis B virus infection. Survival in chronic hepatitis B.

An analysis of patients. Ann Intern Med. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Alpha-fetoprotein monitoring in Chinese patients with chronic hepatitis B virus infection: role in the early detection of hepatocellular carcinoma.

Serum markers of hepatocellular carcinoma. Semin Liver Dis. Dienstag JL. Hepatitis B as an immune complex disease. Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun. The pathogenesis of arthritis associated with viral hepatitis. Complement-component studies. Association between polyarteritis and Australia antigen. Membranous nephropathy related to hepatitis B virus in adults.

Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children. Clinical features and the natural course of hepatitis B virus-related glomerulopathy in adults. Kidney Int Suppl. Hepatitis B virus infection in patients with idiopathic liver disease. Characterization and biological properties of a hepatitis B isolated from a patient without HBV serologic markers. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen.

Nat Med. Persistent viremia after recovery from self-limited acute hepatitis B. Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues.

Transmission of hepatitis B from hepatitis-B-seronegative subjects. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies: report on three cases and review of the literature.

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Because amplification and detection are performed simultaneously, amplification products are measured during the exponential phase of DNA amplification regardless of the initial target concentration. Monday through Saturday.

This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Excel Pdf. Normal Reports Abnormal Reports. Test Catalog Test Catalog. Contact Search. Search Cancel. Home Test Catalog Overview. Test Catalog.

Order This Test. Useful For Suggests clinical disorders or settings where the test may be helpful. Testing Algorithm Delineates situations when tests are added to the initial order. This includes reflex and additional tests. Method Name A short description of the method used to perform the test. Real-Time Polymerase Chain Reaction. Reporting Name Lists a shorter or abbreviated version of the Published Name for a test.

Aliases Lists additional common names for a test, as an aid in searching. Specimen Type Describes the specimen type validated for testing. Specimen Required Defines the optimal specimen required to perform the test and the preferred volume to complete testing. Aliquot serum into plastic vial. If not ordering electronically, complete, print, and send 1 of the following forms with the specimen: - General Request T - Gastroenterology and Hepatology Client Test Request T Specimen Minimum Volume Defines the amount of sample necessary to provide a clinically relevant result as determined by the Testing Laboratory.

Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected. Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included. Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test.